Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NIH ODS And NCCAM Name New Directors

This article was originally published in The Tan Sheet

Executive Summary

The National Institutes of Health Office of Dietary Supplements and National Center for Complementary and Alternative Medicine have appointed new directors. National Institute of Diabetes & Digestive & Kidney Diseases Office of Nutrition Research Coordination Deputy Director Paul Coates, PhD, will head ODS beginning Oct. 25. National Institute of Allergy and Infectious Diseases Laboratory of Clinical Investigation Chief Stephen Straus, MD, took the NCCAM helm Oct. 6.

You may also be interested in...



NIH Office of Dietary Supplements

Bernadette Marriott, PhD, leaves the director position Jan. 8 to join Northern Arizona University as vice provost for research and graduate studies and dean of the graduate school, starting Feb. 1. Appointed as the first director of the NIH office in November 1995, Marriott will be succeeded by Deputy Director Rebecca Costello, PhD, who will serve as interim head until a permanent director is appointed. A search committee to be lead by NIH Associate Director for Disease Prevention William Harlan, MD, is being formed

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090416

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel